Botulinum toxin treatment of secretory disorders
Authors:
- 1 March 2004
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 19 (S8) , S137-S141
Abstract
Botulinum neurotoxin serotype A (BoNT/A) has revolutionised the treatment of a variety of autonomic hypersecretory disorders. Several open and controlled studies indicate that BoNT/A is a safe and effective treatment for focal hyperhidrosis of the axillae and palms, for gustatory sweating, and for some other rare conditions associated with focal hyperhidrosis. There is class I evidence for the efficacy of botulinum toxin in axillary hyperhidrosis and class II evidence for palmar hyperhidrosis and gustatory sweating. BoNT/A has the potential to replace current invasive and surgical techniques and should at least be considered as a viable alternative. The results of pilot studies to treat sialorrhea are encouraging. However, the optimal dose, best mode of application, side effects, and duration of BoNT/A action in this condition remain uncertain. We need further formal clinical trials to evaluate risks and benefits of BoNT/A for palliative treatment in of sialorrhea in Parkinson's disease and in bulbar amyotrophic lateral sclerosis. Based on the few reports published, BoNT/A injections into the lacrimal gland for hyperlacrimation may be an elegant method to treat this sometimes disabling condition. Again, larger studies are needed to evaluate the risks and long‐term benefits of this treatment option. © 2004 Movement Disorder SocietyKeywords
This publication has 37 references indexed in Scilit:
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trialBMJ, 2001
- Botulinum toxin type A therapy for palmar and digital hyperhidrosisJournal of the American Academy of Dermatology, 2000
- Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditionsEuropean Journal of Neurology, 1999
- Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experienceEuropean Journal of Neurology, 1999
- A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosisBritish Journal of Dermatology, 1999
- Recurrent Gustatory Sweating (Frey Syndrome) After Intracutaneous Injection of Botulinum Toxin Type AJAMA Otolaryngology–Head & Neck Surgery, 1999
- Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in applicationBritish Journal of Dermatology, 1998
- Focal HyperhidrosisArchives of Dermatology, 1998
- Botulinum toxin for palmar hyperhidrosisThe Lancet, 1997
- Botulinum toxin and sweating.Journal of Neurology, Neurosurgery & Psychiatry, 1994